Mazor Robotics (NASDAQ:MZOR) was the target of a significant growth in short interest during the month of March. As of March 29th, there was short interest totalling 3,081,432 shares, a growth of 48.6% from the March 15th total of 2,074,187 shares. Based on an average trading volume of 812,561 shares, the short-interest ratio is currently 3.8 days.
Several equities analysts have recently commented on MZOR shares. Needham & Company LLC lowered shares of Mazor Robotics from a “hold” rating to an “underperform” rating in a research report on Friday, March 16th. Barclays reaffirmed a “sell” rating and issued a $36.00 price objective on shares of Mazor Robotics in a report on Tuesday, January 9th. Zacks Investment Research downgraded shares of Mazor Robotics from a “buy” rating to a “hold” rating in a report on Saturday, January 13th. BidaskClub raised shares of Mazor Robotics from a “hold” rating to a “buy” rating in a report on Saturday, January 13th. Finally, Vetr raised shares of Mazor Robotics from a “hold” rating to a “strong-buy” rating and set a $77.50 price objective for the company in a report on Monday, March 19th. Three analysts have rated the stock with a sell rating, five have given a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus price target of $49.21.
MZOR stock opened at $61.92 on Friday. The stock has a market capitalization of $1,533.62, a P/E ratio of -123.84 and a beta of 1.20. Mazor Robotics has a fifty-two week low of $29.55 and a fifty-two week high of $76.56.
A number of hedge funds have recently bought and sold shares of MZOR. Global X Management Co. LLC lifted its holdings in Mazor Robotics by 127.8% in the fourth quarter. Global X Management Co. LLC now owns 263,147 shares of the medical instruments supplier’s stock worth $13,578,000 after purchasing an additional 147,611 shares during the period. Jane Street Group LLC lifted its holdings in Mazor Robotics by 767.0% in the 4th quarter. Jane Street Group LLC now owns 46,384 shares of the medical instruments supplier’s stock valued at $2,517,000 after acquiring an additional 41,034 shares during the last quarter. Raymond James & Associates lifted its holdings in Mazor Robotics by 87.6% in the 4th quarter. Raymond James & Associates now owns 83,151 shares of the medical instruments supplier’s stock valued at $4,291,000 after acquiring an additional 38,820 shares during the last quarter. Taylor Frigon Capital Management LLC acquired a new stake in Mazor Robotics in the 4th quarter valued at about $1,965,000. Finally, Dorsey Wright & Associates lifted its holdings in Mazor Robotics by 37.0% in the 4th quarter. Dorsey Wright & Associates now owns 121,540 shares of the medical instruments supplier’s stock valued at $6,272,000 after acquiring an additional 32,828 shares during the last quarter. 24.08% of the stock is owned by institutional investors and hedge funds.
ILLEGAL ACTIVITY WARNING: This news story was reported by Dakota Financial News and is the sole property of of Dakota Financial News. If you are accessing this news story on another publication, it was copied illegally and reposted in violation of international trademark and copyright laws. The legal version of this news story can be read at https://dakotafinancialnews.com/2018/04/14/mazor-robotics-mzor-short-interest-update.html.
Mazor Robotics Company Profile
Mazor Robotics Ltd., together with its subsidiaries, engages in the development, production, and marketing of medical devices for supporting surgical procedures in the fields of orthopedics and neurosurgery in the United States and internationally. The company operates in the field of image guided surgery and computer assisted surgery that enable the use of surgical instruments with high precision and minimal invasiveness.
Receive News & Ratings for Mazor Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mazor Robotics and related companies with MarketBeat.com's FREE daily email newsletter.